12306-1-AP
antibody from Proteintech Group
Targeting: ZFP36L1
Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12306-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12306-1-AP, RRID:AB_2737443
- Product name
- ZFP36L1/2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ZFP36L1/2 antibody (Cat. #12306-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation.
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
The miR-93-3p/ZFP36L1/ZFX axis regulates keratinocyte proliferation and migration during skin wound healing.
ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1.
A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 3'UTR-Mediated Protein-Protein Interactions.
Scinicariello S, Soderholm A, Schäfer M, Shulkina A, Schwartz I, Hacker K, Gogova R, Kalis R, Froussios K, Budroni V, Bestehorn A, Clausen T, Kovarik P, Zuber J, Versteeg GA
eLife 2023 Mar 24;12
eLife 2023 Mar 24;12
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
Tan X, Xiao GY, Wang S, Shi L, Zhao Y, Liu X, Yu J, Russell WK, Creighton CJ, Kurie JM
The Journal of clinical investigation 2023 Apr 3;133(7)
The Journal of clinical investigation 2023 Apr 3;133(7)
The miR-93-3p/ZFP36L1/ZFX axis regulates keratinocyte proliferation and migration during skin wound healing.
Feng X, Zhou S, Cai W, Guo J
Molecular therapy. Nucleic acids 2021 Mar 5;23:450-463
Molecular therapy. Nucleic acids 2021 Mar 5;23:450-463
ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1.
Wu F, Huang W, Tan Q, Guo Y, Cao Y, Shang J, Ping F, Wang W, Li Y
Cell death & disease 2021 Jun 15;12(6):614
Cell death & disease 2021 Jun 15;12(6):614
A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 3'UTR-Mediated Protein-Protein Interactions.
Ma W, Mayr C
Cell 2018 Nov 29;175(6):1492-1506.e19
Cell 2018 Nov 29;175(6):1492-1506.e19
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ZFP36L1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ZFP36L1. This antibody recognizes human,mouse,rat antigen. The ZFP36L1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.